192 related articles for article (PubMed ID: 9205738)
1. Synthesis and assessment of formamidines as new histamine H2-receptor antagonists.
Anglada L; Raga M; Márquez M; Sacristán A; Castelló JM; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):431-4. PubMed ID: 9205738
[TBL] [Abstract][Full Text] [Related]
2. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
[TBL] [Abstract][Full Text] [Related]
3. Action of ebrotidine, ranitidine and cimetidine on the specific binding to histamine H1- and H2-receptors.
Agut J; Sánchez JC; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):447-9. PubMed ID: 9205741
[TBL] [Abstract][Full Text] [Related]
4. Effect of ebrotidine on ethanol-induced gastric mucosal damage in the rat. Comparative study with other H2-receptor antagonists.
Palop D; Romero A; Villamayor F; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):450-4. PubMed ID: 9205742
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Sekiguchi H; Hamada K; Kobayashi F; Taga F; Uchida H
Arzneimittelforschung; 1993 Feb; 43(2):129-33. PubMed ID: 8096132
[TBL] [Abstract][Full Text] [Related]
6. Studies on the cytoprotective and antisecretory activity of ebrotidine. A review.
Konturek PC; Brzozowski T; Konturek SI; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):578-89. PubMed ID: 9205769
[TBL] [Abstract][Full Text] [Related]
7. Study on the increment of the amount of gastric mucus in rats after repeated-dose administration of ebrotidine.
Romero A; Villamayor F; Palop D; Falcó J; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):455-8. PubMed ID: 9205743
[TBL] [Abstract][Full Text] [Related]
8. Histamine H2 receptor antagonists. 1. Synthesis of N-cyano and N-carbamoyl amidine derivatives and their biological activities.
Yanagisawa I; Hirata Y; Ishii Y
J Med Chem; 1984 Jul; 27(7):849-57. PubMed ID: 6145803
[TBL] [Abstract][Full Text] [Related]
9. Involvement of endogenous nitric oxide and sulfhydryl compounds in ebrotidine-induced gastroprotection.
Palop D; Conejo L; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):468-71. PubMed ID: 9205745
[TBL] [Abstract][Full Text] [Related]
10. Studies on histamine H2 receptor antagonists. 2. Synthesis and pharmacological activities of N-sulfamoyl and N-sulfonyl amidine derivatives.
Yanagisawa I; Hirata Y; Ishii Y
J Med Chem; 1987 Oct; 30(10):1787-93. PubMed ID: 2888895
[TBL] [Abstract][Full Text] [Related]
11. Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles.
Katsura Y; Nishino S; Ohno M; Sakane K; Matsumoto Y; Morinaga C; Ishikawa H; Takasugi H
J Med Chem; 1999 Jul; 42(15):2920-6. PubMed ID: 10425101
[TBL] [Abstract][Full Text] [Related]
12. Studies on the protective effect of ebrotidine on experimental ulcers induced by non-steroidal anti-inflammatory drugs in healthy volunteers.
Puscas I; Puscas C; Coltau M; Torres J; Márquez M; Herrero E; Fillat O; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):565-8. PubMed ID: 9205766
[TBL] [Abstract][Full Text] [Related]
13. Continuous intragastric pH monitoring in the evaluation of ebrotidine, cimetidine and placebo on gastric acidity in healthy volunteers.
Muñoz-Navas M; Honorato J; Reina-Ariño M; Márquez M; Herrero E; Villamayor F; Torres J; Roset PN; Fíllat O; Camps F; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):539-44. PubMed ID: 9205761
[TBL] [Abstract][Full Text] [Related]
14. Gastroprotective properties of ebrotidine. A review.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):459-67. PubMed ID: 9205744
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of gastric acid secretion by H2-receptor antagonists.
Nielsen ST
Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):151-60. PubMed ID: 2876686
[TBL] [Abstract][Full Text] [Related]
16. Acute toxicity studies of ebrotidine.
Grau MT; Romero A; Villamayor F; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):490-1. PubMed ID: 9205750
[TBL] [Abstract][Full Text] [Related]
17. Anti-Helicobacter pylori activities of ebrotidine. A review of biochemical and animal experimental studies and data.
Slomiany BL; Piotrowski J; Slomiany A
Arzneimittelforschung; 1997 Apr; 47(4A):475-82. PubMed ID: 9205747
[TBL] [Abstract][Full Text] [Related]
18. Study of the population of antral G-cells and enterochromaffin-like cells in the rat and mouse gastric mucosa after long-term treatment with ebrotidine.
Romero A; Gómez F; Villamayor F; Sacristán A; Ortiz JA
Arzneimittelforschung; 1997 Apr; 47(4A):520-3. PubMed ID: 9205756
[TBL] [Abstract][Full Text] [Related]
19. H2-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives.
Plazzi PV; Bordi F; Silva C; Morini G; Catellani PL; Vaona G; Impicciatore M
Farmaco; 1989 Nov; 44(11):1011-30. PubMed ID: 2577150
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and activity of pyridine analogues of histamine H2-receptor antagonists.
Agrawal VK; Tang SB; Wolowyk MW; Knaus EE
Drug Des Deliv; 1988 Dec; 3(4):297-307. PubMed ID: 2908227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
